{"DataElement":{"publicId":"6741251","version":"1","preferredName":"Cutaneous T-cell Lymphoma Response in Skin Category","preferredDefinition":"Response category that describes the disease involvement in skin based on staging and classification criteria for cutaneous T-cell lymphoma (CTCL).","longName":"CTCL_SKIN_SCR_CAT","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6741240","version":"1","preferredName":"Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Global Response in Skin","preferredDefinition":"A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma._Criteria for the response to treatment in skin lesions, as a component of global response.","longName":"6741233v1.0:6741238v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6741233","version":"1","preferredName":"Primary Cutaneous T-Cell Non-Hodgkin Lymphoma","preferredDefinition":"A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma.","longName":"C3467","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Cutaneous T-Cell Non-Hodgkin Lymphoma","conceptCode":"C3467","definition":"A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A32B7-C39E-1131-E053-F662850AA707","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6741238","version":"1","preferredName":"Global Response in Skin","preferredDefinition":"Criteria for the response to treatment in skin lesions, as a component of global response.","longName":"C159951","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Response in Skin","conceptCode":"C159951","definition":"Criteria for the response to treatment in skin lesions, as a component of global response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A4300-312C-215E-E053-F662850A115A","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A4300-313D-215E-E053-F662850A115A","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeDescription":"Created for NCI-INC0370865: 19C0076 qns curation request. 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6741206","version":"1","preferredName":"Global Response in Skin Category","preferredDefinition":"Criteria for the response to treatment in skin lesions, as a component of global response._A grouping of items based on some commonality or by user defined characteristics.","longName":"GR_SKIN_CAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CR","valueDescription":"Global Complete Response in Skin","ValueMeaning":{"publicId":"6741207","version":"1","preferredName":"Global Complete Response in Skin","longName":"6741207","preferredDefinition":"100 percent clearance of skin lesions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Complete Response in Skin","conceptCode":"C159952","definition":"100 percent clearance of skin lesions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-DA1D-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88392B4A-DA36-2D5D-E053-F662850A4494","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"PD","valueDescription":"Global Progressive Disease in Skin","ValueMeaning":{"publicId":"6741208","version":"1","preferredName":"Global Progressive Disease in Skin","longName":"6741208","preferredDefinition":"25 percent or greater increase in skin disease from baseline; or new tumors (T3) in patients with T1, T2, or T4 only skin disease; or loss of response: in those with complete or partial response, increase of skin score of greater than the sum of nadir plus 50 percent baseline score.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Progressive Disease in Skin","conceptCode":"C159955","definition":"25 percent or greater increase in skin disease from baseline; or new tumors (T3) in patients with T1, T2, or T4 only skin disease; or loss of response: in those with complete or partial response, increase of skin score of greater than the sum of nadir plus 50 percent baseline score.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-DA42-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88392B4A-DA5B-2D5D-E053-F662850A4494","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"PR","valueDescription":"Global Partial Response in Skin","ValueMeaning":{"publicId":"6741209","version":"1","preferredName":"Global Partial Response in Skin","longName":"6741209","preferredDefinition":"50-99 percent clearance of skin disease from baseline without new tumors (T3) in patients with T1, T2, or T4 only skin disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Partial Response in Skin","conceptCode":"C159953","definition":"50-99 percent clearance of skin disease from baseline without new tumors (T3) in patients with T1, T2, or T4 only skin disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-DA67-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88392B4A-DA80-2D5D-E053-F662850A4494","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"Relapse","valueDescription":"Global Relapse in Skin","ValueMeaning":{"publicId":"6741210","version":"1","preferredName":"Global Relapse in Skin","longName":"6741210","preferredDefinition":"Any disease recurrence in those with complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Relapse in Skin","conceptCode":"C159956","definition":"Any disease recurrence in those with complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-DA8C-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88392B4A-DAA5-2D5D-E053-F662850A4494","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"SD","valueDescription":"Global Stable Disease in Skin","ValueMeaning":{"publicId":"6741211","version":"1","preferredName":"Global Stable Disease in Skin","longName":"6741211","preferredDefinition":"Less than 25 percent increase to less than 50 percent clearance in skin disease from baseline without new tumors (T3) in patients with T1, T2, or T4, only skin disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Stable Disease in Skin","conceptCode":"C159954","definition":"Less than 25 percent increase to less than 50 percent clearance in skin disease from baseline without new tumors (T3) in patients with T1, T2, or T4, only skin disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-DAB1-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88392B4A-DACA-2D5D-E053-F662850A4494","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6741205","version":"1","preferredName":"Global Response in Skin Category","preferredDefinition":"Criteria for the response to treatment in skin lesions, as a component of global response.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C159951:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Response in Skin","conceptCode":"C159951","definition":"Criteria for the response to treatment in skin lesions, as a component of global response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-D9F4-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-DA05-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeDescription":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Response in Skin","type":"Preferred Question Text","description":"Response in Skin","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A69D8-CC1A-2BF7-E053-F662850A376B","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-08","changeDescription":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}